Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Dengue virus non-structural protein 5 (NS5) is a highly conserved, multifunctional enzyme that serves as the primary catalytic driver of the viral replication cycle [2, 11]. It consists of two essential domains: an N-terminal methyltransferase (MTase) responsible for viral RNA capping and a C-terminal RNA-dependent RNA polymerase (RdRp) that synthesizes the viral RNA genome [14, 17]. These activities are crucial for the production of new viral genetic material and for protecting viral RNA from detection by the host's innate immune system [11, 22]. NS5 functions within a large replication complex on the endoplasmic reticulum membranes of infected cells, where it interacts with other viral proteins such as the NS3 protease-helicase and NS4B to coordinate replication and assembly [6, 8, 21]. Given its vital role and the absence of a direct human homolog, NS5 is a premier target for direct-acting antivirals, including nucleoside and non-nucleoside inhibitors [12, 15, 19]. Successful therapeutic intervention requires achieving broad-spectrum efficacy across all four distinct Dengue virus serotypes while avoiding off-target effects on host cell polymerases [10, 11, 24].
Inhibition of RNA-dependent RNA polymerase activity, inhibition of viral RNA methyltransferase activity, antagonism of NS4B protein within the replication complex, and inhibition of viral polyprotein processing.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dengue virus non-structural protein 5 (NS5) (NS5).